Trials / Completed
CompletedNCT01374360
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,061 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).
Detailed description
Collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).
Conditions
Timeline
- Start date
- 2004-10-29
- Primary completion
- 2025-04-14
- Completion
- 2025-04-14
- First posted
- 2011-06-16
- Last updated
- 2026-01-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01374360. Inclusion in this directory is not an endorsement.